相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapeutic Potential of Cannabinoids in Psychosis
F. Markus Leweke et al.
BIOLOGICAL PSYCHIATRY (2016)
An update on PPAR activation by cannabinoids
Saoirse Elizabeth O'Sullivan
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Neurovascular and Cognitive failure in Alzheimer's Disease: Benefits of Cardiovascular Therapy
Edith Hamel et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2016)
Pathophysiological Links Among Hypertension and Alzheimer's Disease
Daniela Carnevale et al.
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION (2016)
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses
Valerio Chiurchiu et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2015)
NEURONAL EXPRESSION OF CB2 CANNABINOID RECEPTOR mRNAs IN THE MOUSE HIPPOCAMPUS
Y. Li et al.
NEUROSCIENCE (2015)
Vascular targets for cannabinoids: animal and human studies
Christopher Stanley et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Evaluation of the specificity of antibodies raised against cannabinoid receptor type 2 in the mouse retina
Bruno Cecyre et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2014)
β-Caryophyllene Ameliorates the Alzheimer-Like Phenotype in APP/PS1 Mice through CB2 Receptor Activation and the PPARγ Pathway
Yujie Cheng et al.
PHARMACOLOGY (2014)
The cerebrovascular basement membrane: role in the clearance of β-amyloid and cerebral amyloid angiopathy
Alan W. J. Morris et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic
Ester Aso et al.
FRONTIERS IN PHARMACOLOGY (2014)
Activation of the CB2 receptor system reverses amyloid-induced memory deficiency
Jiang Wu et al.
NEUROBIOLOGY OF AGING (2013)
A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: Potential extinction enhancers
Rafael Mariano de Bitencourt et al.
NEUROPHARMACOLOGY (2013)
Hypertension Induces Brain β-Amyloid Accumulation, Cognitive Impairment, and Memory Deterioration Through Activation of Receptor for Advanced Glycation End Products in Brain Vasculature
Daniela Carnevale et al.
HYPERTENSION (2012)
Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice
Ana Maria Martin-Moreno et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities
Roger G. Pertwee
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Why do cannabinoid receptors have more than one endogenous ligand?
Vincenzo Di Marzo et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Prospects for cannabinoid therapies in basal ganglia disorders
Javier Fernandez-Ruiz et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's disease
Paula Grammas
JOURNAL OF NEUROINFLAMMATION (2011)
The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia
Costantino Iadecola
ACTA NEUROPATHOLOGICA (2010)
CB2: a cannabinoid receptor with an identity crisis
Brady K. Atwood et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies
A. Arevalo-Martin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Vasorelaxation Caused by Cannabinoids: Mechanisms in Different Vascular Beds
Visitacion Lopez-Miranda et al.
CURRENT VASCULAR PHARMACOLOGY (2008)
Cortical expression of brain derived neurotrophic factor and type-1 cannabinoid receptor after striatal excitotoxic lesions
Z. De March et al.
NEUROSCIENCE (2008)
Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors
S. E. O'Sullivan
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Native and oxidized low-density lipoproteins modulate the vasoactive actions of soluble β-amyloid peptides in rat aorta
Christopher C. T. Smith et al.
CLINICAL SCIENCE (2007)
Vascular remodeling versus amyloid β-induced oxidative stress in the cerebrovascular dysfunctions associated with Alzheimer's disease
XK Tong et al.
JOURNAL OF NEUROSCIENCE (2005)
Cerebral microvascular amyloid β protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid β precursor protein
J Miao et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Prevention of Alzheimer's disease pathology by cannabinoids:: Neuroprotection mediated by blockade of microglial activation
BG Ramírez et al.
JOURNAL OF NEUROSCIENCE (2005)
Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis
D Paris et al.
NEUROSCIENCE LETTERS (2004)
Immunohistochemical localization of cerebrovascular cannabinoid CB1 receptor protein
JC Ashton et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2004)
Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway
TG del Pulgar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The endogenous cannabinoid system controls extinction of aversive memories
G Marsicano et al.
NATURE (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
Small vessel disease and Alzheimer's dementia: Pathological considerations
RN Kalaria
CEREBROVASCULAR DISEASES (2002)
Regional haemodynamic responses to the cannabinoid agonist, WIN 55212-2, in conscious, normotensive rats, and in hypertensive, transgenic rats
SM Gardiner et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy
R Christie et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Cannabinoids control spasticity and tremor in a multiple sclerosis model
D Baker et al.
NATURE (2000)
The pattern of neurodegeneration in Huntington's disease: A comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease
M Glass et al.
NEUROSCIENCE (2000)
分享论文
